Jefferies Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-92,300
Closed -$9.09M 2321
2017
Q4
$9.09M Sell
92,300
-5,100
-5% -$483K 0.04% 334
2017
Q3
$9.12M Buy
97,400
+44,300
+83% +$4.7M 0.06% 300
2017
Q2
$5.9M Hold
53,100
0.04% 460
2017
Q1
$5.21M Buy
+53,100
New +$5.06M 0.04% 487
2016
Q4
Sell
-95,000
Closed -$8.04M 2251
2016
Q3
$8.04M Sell
95,000
-31,500
-25% -$2.65M 0.04% 379
2016
Q2
$10.3M Buy
126,500
+35,800
+39% +$2.73M 0.05% 284
2016
Q1
$6.48M Buy
90,700
+29,900
+49% +$2.01M 0.04% 398
2015
Q4
$4.33M Sell
60,800
-35,200
-37% -$2.37M 0.02% 535
2015
Q3
$5.9M Buy
+96,000
New +$6.71M 0.03% 421
2015
Q2
Sell
-125,200
Closed -$9.62M 3336
2015
Q1
$9.62M Buy
125,200
+120,200
+2,404% +$8.61M 0.05% 247
2014
Q4
$335K Sell
5,000
-67,200
-93% -$4.24M ﹤0.01% 1476
2014
Q3
$4.38M Buy
72,200
+13,700
+23% +$844K 0.03% 466
2014
Q2
$3.43M Buy
+58,500
New +$3.43M 0.03% 447
2014
Q1
Sell
-48,100
Closed -$2.58M 2092
2013
Q4
$2.58M Buy
+48,100
New +$2.85M 0.02% 495

Other funds holding DGX

Jefferies Group's DGX Position: Q3 2022 in Review

Jefferies Group opened a new position in Quest Diagnostics (DGX) in Q3 2022: 34,200 shares worth $4.2M. The stake represents 0.04% of the portfolio and ranks #382 among its holdings. This is a return to the name: Jefferies Group previously reported a position in DGX as recently as Q4 2021.

Jefferies Group first reported a position in DGX in Q2 2013 and has held it in 27 quarters since. The position peaked at $19.7M in Q2 2021. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Jefferies Group held 34,200 shares of Quest Diagnostics worth $4.2M as of Q3 2022.
  • Quest Diagnostics was a new Jefferies Group position in Q3 2022.
  • Quest Diagnostics made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #382 holding.
  • Jefferies Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 27 quarters since.
  • Jefferies Group's Quest Diagnostics position peaked at $19.7M in Q2 2021.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.